In addition, univariate and multivariate Cox analyses demonstrated that ESPL1 expression might be a useful biomarker for glioma prognosis and that ROC analysis confirmed the diagnostic value of ESPL1 expression in glioma. The gene discussed is ESPL1; the disease is central nervous system cancer.